Fibrosing Alveolitis

Common Name(s)

Fibrosing Alveolitis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fibrosing Alveolitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Fibrosing Alveolitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Fibrosing Alveolitis" returned 122 free, full-text research articles on human participants. First 3 results:

Fatal fibrosing alveolitis with certolizumab.
 

Author(s): Auleen Millar, Jennifer McKew, Allister Taggart

Journal: Rheumatology (Oxford). 2012 May;51(5):953-5.

 

Last Updated: 17 Apr 2012

Go To URL
Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
 

Author(s): Yu-Cheng Hsieh, Jin-Long Huang, Chun-Shih Chin, Tung-Chao Lin, Ying-Chieh Liao, Chih-Tai Ting, Tsu-Juey Wu

Journal: Europace. 2011 Jan;13(1):137-9.

 

A 66-year-old male received an implant of a dual-chamber implantable cardioverter-defibrillator (ICD) and was prescribed amiodarone (400 mg/day). The intra-thoracic impedance monitor in the ICD antecedently detected amiodarone-induced acute fibrosing alveolitis >3 months prior to clinical symptoms.

Last Updated: 14 Dec 2010

Go To URL
British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival.
 

Author(s): Robin M Rudd, Robin J Prescott, J C Chalmers, Ian D A Johnston,

Journal: Thorax. 2007 Jan;62(1):62-6.

 

The initial results of a survey of 588 patients with a clinical presentation of cryptogenic fibrosing alveolitis (CFA) also known as idiopathic pulmonary fibrosis, have been published. This article reports further results pertaining to response to treatment and survival.

Last Updated: 25 Dec 2006

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Fibrosing Alveolitis" returned 12 free, full-text review articles on human participants. First 3 results:

Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab.
 

Author(s): Y Allanore, G Devos-Fran├žois, C Caramella, P Boumier, V Jounieaux, A Kahan

Journal: Ann. Rheum. Dis.. 2006 Jun;65(6):834-5.

 

Last Updated: 15 May 2006

Go To URL
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis.
 

Author(s): R M du Bois, A U Wells

Journal: Eur Respir J Suppl. 2001 Sep;32():43s-55s.

 

Cryptogenic fibrosing alveolitis (CFA), synonymous with idiopathic pulmonary fibrosis (IPF), remains a life-threatening disease: 50% of patients die within 5 yrs. Historically, many diseases that are now considered to be quite distinct have been "labelled" as CFA. More recently, high-resolution ...

Last Updated: 5 Dec 2001

Go To URL
Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis.
 

Author(s): R Hubbard

Journal: Eur Respir J Suppl. 2001 Sep;32():119s-121s.

 

Cryptogenic fibrosing alveolitis (CFA), synonymous with idiopathic pulmonary fibrosis, is probably a disease entity of increasing frequency. Epidemiological investigations into the aetiology of CFA are at an early age; yet there are several indications that exposures associated with ...

Last Updated: 5 Dec 2001

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
 

Status: Recruiting

Condition Summary: Idiopathic Pulmonary Fibrosis

 

Last Updated: 16 Aug 2007

Go to URL
Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
 

Status: Recruiting

Condition Summary: Idiopathic Pulmonary Fibrosis

 

Last Updated: 22 Jun 2012

Go to URL
Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
 

Status: Recruiting

Condition Summary: Idiopathic Pulmonary Fibrosis

 

Last Updated: 11 Sep 2014

Go to URL